Thomas M Gress is an expert in Gastroenterology at Universitätsklinikum Gießen und Marburg (Germany). As of July 2026, ScienceLeadR ranks Thomas M Gress in the top 1% of experts worldwide for Pancreatic Neoplasms, Pancreatic Diseases and Endocrine Gland Neoplasms. Thomas M Gress has authored 438 publications, the most recent in 2026, and is an investigator in 3 clinical trials. SLR score: 1,209 (community average: 125). How the SLR is computed.

LeadR Profile

1 209 ScienceLeadR Reputation 1209
Network Map

Gastroenterology

Subspecialties: Oncology - Hepatology - Public Health

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 1990 - 2026

Source: PubMed

Philipp University of Marburg

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 438

Citations

Citations: 34 463 1st author: 20 Last author: 84 Unique author: 2


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Optimized precision oncology through implementation of a comprehensive molecular analysis pipeline - relevance for additional therapeutic options.
PMID 41950859 — genes, neoplasms, therapeutics
Cancer Genet20260
A Comprehensive Assessment of the Causal Relationship Between Atopic Conditions and Pancreatic Cancer Risk: A Two-Sample Mendelian Randomization Study.
PMID 41910234 — pancreatic neoplasms, neoplasms, rhinitis, asthma, random allocation
Cancer Epidemiol Biomarkers Prev20260
Publisher Correction: Deciphering the role of complement system genes in pancreatic cancer susceptibility and prognosis.
PMID 41629317 — genes, pancreatic neoplasms, biological science disciplines, neoplasms, complement system proteins, prognosis
Nat Commun20260
Deciphering the role of complement system genes in pancreatic cancer susceptibility and prognosis.
PMID 41315260 — cells, genes, pancreatic neoplasms, biological science disciplines, genetic predisposition to disease, neoplasms, complement system proteins, prognosis
Nat Commun20250
Maintenance treatment for type 1 autoimmune pancreatitis: effectiveness and development of the PrescrAIP relapse prediction model.
PMID 40953780 — digestive system diseases, maintenance, pancreatitis, autoimmune pancreatitis, therapeutics
Clin Gastroenterol Hepatol20250

Clinical Studies 3

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1

By phase:

Phase 2 2
Phase 3 1

By status:

Completed 2
Unknown 1

By type:

Interventional 3

By Monocentric/Multicentric:

monocentric 0
multicentric2to4 0
multicentric5to9 2
multicentricup10 1

Main Topics

LeadR Networks

Main global connection map